IL113339A - Mutant viral nucleotide sequences - Google Patents
Mutant viral nucleotide sequencesInfo
- Publication number
- IL113339A IL113339A IL113339A IL11333989A IL113339A IL 113339 A IL113339 A IL 113339A IL 113339 A IL113339 A IL 113339A IL 11333989 A IL11333989 A IL 11333989A IL 113339 A IL113339 A IL 113339A
- Authority
- IL
- Israel
- Prior art keywords
- gene
- ribonucleotide reductase
- mutation
- large subunit
- nucleotide sequences
- Prior art date
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 102000000505 Ribonucleotide Reductases Human genes 0.000 abstract 4
- 108010041388 Ribonucleotide Reductases Proteins 0.000 abstract 4
- 102000006601 Thymidine Kinase Human genes 0.000 abstract 4
- 108020004440 Thymidine kinase Proteins 0.000 abstract 4
- 241000701063 Gallid alphaherpesvirus 1 Species 0.000 abstract 3
- 241001502481 Meleagrid alphaherpesvirus 1 Species 0.000 abstract 3
- 230000035772 mutation Effects 0.000 abstract 3
- 241000271566 Aves Species 0.000 abstract 2
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 abstract 2
- 108700026244 Open Reading Frames Proteins 0.000 abstract 2
- 101150002378 gC gene Proteins 0.000 abstract 2
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 abstract 1
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 abstract 1
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 abstract 1
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 abstract 1
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 abstract 1
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 abstract 1
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 abstract 1
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 abstract 1
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 abstract 1
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 abstract 1
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 abstract 1
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 abstract 1
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 abstract 1
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 abstract 1
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 abstract 1
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 abstract 1
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 abstract 1
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 abstract 1
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 abstract 1
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 abstract 1
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 abstract 1
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 abstract 1
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 abstract 1
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 abstract 1
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 abstract 1
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 abstract 1
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 abstract 1
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 abstract 1
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 abstract 1
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 abstract 1
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 abstract 1
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 abstract 1
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 abstract 1
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 abstract 1
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 abstract 1
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 abstract 1
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 abstract 1
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 abstract 1
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 abstract 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 abstract 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 abstract 1
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 abstract 1
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 abstract 1
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 abstract 1
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 abstract 1
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 abstract 1
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 abstract 1
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 abstract 1
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 abstract 1
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 abstract 1
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 abstract 1
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 abstract 1
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 abstract 1
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 abstract 1
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 abstract 1
- 108700005077 Viral Genes Proteins 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0093—Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888821441A GB8821441D0 (en) | 1988-09-13 | 1988-09-13 | Viral vectors |
| IL9162789A IL91627A (en) | 1988-09-13 | 1989-09-13 | Viral nucleotide segments |
| US08/654,931 US5744143A (en) | 1988-09-13 | 1996-05-29 | Viral vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL113339A true IL113339A (en) | 1997-03-18 |
Family
ID=26294384
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL113339A IL113339A (en) | 1988-09-13 | 1989-09-13 | Mutant viral nucleotide sequences |
| IL9162789A IL91627A (en) | 1988-09-13 | 1989-09-13 | Viral nucleotide segments |
| IL11333995A IL113339A0 (en) | 1988-09-13 | 1995-04-12 | Mutant viral nucleotide sequences |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9162789A IL91627A (en) | 1988-09-13 | 1989-09-13 | Viral nucleotide segments |
| IL11333995A IL113339A0 (en) | 1988-09-13 | 1995-04-12 | Mutant viral nucleotide sequences |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US5744143A (fr) |
| EP (3) | EP0434747B1 (fr) |
| JP (2) | JP3339854B2 (fr) |
| AU (2) | AU629248B2 (fr) |
| IL (3) | IL113339A (fr) |
| WO (2) | WO1990002802A2 (fr) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5928648A (en) * | 1985-09-06 | 1999-07-27 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
| US5965138A (en) * | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
| IL113339A (en) * | 1988-09-13 | 1997-03-18 | Rhone Merieux | Mutant viral nucleotide sequences |
| FR2659349B1 (fr) * | 1990-03-12 | 1993-12-24 | Rhone Merieux | Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus. |
| US6087127A (en) * | 1990-08-24 | 2000-07-11 | Board Of Trustees Operating Michigan State University | Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE |
| WO1992003554A1 (fr) * | 1990-08-24 | 1992-03-05 | Arthur Webster Pty. Ltd. | Vaccin contre le virus de la laryngotracheite infectieuse |
| FR2666589B1 (fr) * | 1990-09-07 | 1994-08-05 | Rhone Merieux | Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede. |
| NL9002008A (nl) | 1990-09-12 | 1992-04-01 | Stichting Centr Diergeneeskund | Recombinant dna en rna en daarvan afgeleide produkten. |
| EP0486106A3 (en) * | 1990-11-16 | 1992-12-23 | Akzo N.V. | Marek's disease virus vaccine |
| US5759552A (en) * | 1991-03-07 | 1998-06-02 | Virogenetics Corporation | Marek's disease virus recombinant poxvirus vaccine |
| US5369025A (en) * | 1991-06-28 | 1994-11-29 | The United States Of America As Represented By The Secretary Of Agriculture | Recombinant fowlpox vaccine for protection against Marek's disease |
| AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
| US5223408A (en) * | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
| US5443831A (en) * | 1991-10-29 | 1995-08-22 | University Of Delaware | Gene encoding glycoprotein B of Infectious Laryngotracheitis Virus |
| PT623172E (pt) * | 1992-01-13 | 2005-02-28 | Virogenetics Corp | Vacina de virus vaccinia recombinante do virus da doenca de marek |
| US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| US6165993A (en) * | 1992-03-23 | 2000-12-26 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
| US5620896A (en) * | 1992-03-23 | 1997-04-15 | University Of Massachusetts Medical Center | DNA vaccines against rotavirus infections |
| US5853733A (en) * | 1993-02-26 | 1998-12-29 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
| GB9213882D0 (en) * | 1992-06-30 | 1992-08-12 | Univ Court Of The University O | Live modified equine herpesvirus-4 vaccine |
| AU7838694A (en) * | 1993-09-24 | 1995-04-10 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
| US6984728B2 (en) | 1993-09-24 | 2006-01-10 | Schering Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
| EP0750670A1 (fr) * | 1994-02-07 | 1997-01-02 | Cornell Research Foundation, Inc. | Compositions utiles pour traiter la maladie de marek |
| FR2719056B1 (fr) * | 1994-04-20 | 1996-09-06 | Rhone Merieux | Herpesvirus transformés pour exprimer gD in vitro. |
| WO1996000791A1 (fr) * | 1994-06-30 | 1996-01-11 | The Board Of Trustees Of The University Of Illinois | Virus de recombinaison de la laryngo-tracheite infectieuse et vaccin |
| FR2728794B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
| FR2728795B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
| WO1996029396A1 (fr) * | 1995-03-23 | 1996-09-26 | Syntro Corporation | Virus de la laryngotracheite infectieuse recombine et ses utilisations |
| JPH08322559A (ja) * | 1995-06-02 | 1996-12-10 | Chemo Sero Therapeut Res Inst | ｇＢ遺伝子プロモーターを用いた組換えヘルペスウイルス |
| KR19990028766A (ko) * | 1995-07-07 | 1999-04-15 | 나카노 가쓰히꼬 | 마렉 질환 바이러스 유전자 및 마렉 질환 예방용 백신에서그의 용도 |
| FR2750866B1 (fr) * | 1996-06-27 | 1998-11-27 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
| FR2757061B1 (fr) * | 1996-12-16 | 1999-03-26 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
| CN100518827C (zh) * | 2000-10-30 | 2009-07-29 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
| ES2344594T3 (es) | 2001-01-31 | 2010-09-01 | Mayo Foundation For Medical Education And Research | Deteccion del virus del herpes simplex. |
| US7037506B2 (en) * | 2002-03-08 | 2006-05-02 | Schweltzer Chemical Corporation Ltd. | Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
| US7029681B2 (en) * | 2002-03-08 | 2006-04-18 | Schweitzer Chemical Corporation | Multiple and multivalent DNA vaccines in ovo |
| US8754031B2 (en) | 2004-03-08 | 2014-06-17 | Oncolix, Inc. | Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway |
| CA2568642A1 (fr) | 2004-05-27 | 2005-12-15 | Centocor, Inc. | Antigene specifique de la prostate du singe cynomolgus |
| US20050276758A1 (en) * | 2004-06-15 | 2005-12-15 | Marshall Deborah J | Method for screening agents against human prostate disease |
| WO2007022151A2 (fr) | 2005-08-15 | 2007-02-22 | Vaxin, Inc. | Immunisation d'oiseaux par administration de vaccins a vecteurs non repliquants |
| CN100460509C (zh) * | 2007-01-04 | 2009-02-11 | 首都医科大学 | 旋毛虫副肌球蛋白基因及其应用 |
| TW201109913A (en) * | 2009-09-02 | 2011-03-16 | Inventec Corp | Main system board error-detecting system and its pluggable error-detecting board |
| JP2023506919A (ja) | 2019-12-20 | 2023-02-20 | インターベット インターナショナル ベー． フェー． | 多価ｈｖｔベクターワクチン |
| EP4267179A1 (fr) | 2020-12-24 | 2023-11-01 | Intervet International B.V. | Vaccin à vecteur hvt multivalent |
| WO2023213946A1 (fr) | 2022-05-05 | 2023-11-09 | Intervet International B.V. | Nouveau vaccin à vecteur hvt multivalent |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965138A (en) * | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
| WO1987004463A1 (fr) * | 1986-01-27 | 1987-07-30 | Syntro Corporation | Virus herpetiques attenues, virus herpetiques comprenant de l'adn etranger contenant une sequence d'acide amine et vaccin les contenant |
| JPH02502693A (ja) * | 1987-03-19 | 1990-08-30 | サイナーゲン，インコーポレーテッド | 外来ｄｎａ発現産物の家禽類への導入のためのウイルスベクター系およびその作製方法 |
| US4996152A (en) * | 1987-12-04 | 1991-02-26 | The United States Of America, As Represented By The Secretary Of Agriculture | Avian herpesvirus amplicon as a eucaryotic expression vector |
| DE68926712T2 (de) * | 1988-05-02 | 1997-04-17 | The United States Of America, Represented By The Secretary, U.S. Department Of Commerce, Springfield, Va. | Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff |
| IL113339A (en) * | 1988-09-13 | 1997-03-18 | Rhone Merieux | Mutant viral nucleotide sequences |
| US5558860A (en) * | 1988-09-13 | 1996-09-24 | Rhone Merieux | Viral vaccines |
| EP0431668B1 (fr) * | 1989-12-04 | 1995-02-15 | Akzo Nobel N.V. | Virus herpès de dinde recombinant et vaccins-vecteurs vivants dérivés de celui-ci |
-
1989
- 1989-09-13 IL IL113339A patent/IL113339A/xx not_active IP Right Cessation
- 1989-09-13 EP EP89910900A patent/EP0434747B1/fr not_active Expired - Lifetime
- 1989-09-13 WO PCT/GB1989/001075 patent/WO1990002802A2/fr active IP Right Grant
- 1989-09-13 JP JP51023289A patent/JP3339854B2/ja not_active Expired - Lifetime
- 1989-09-13 IL IL9162789A patent/IL91627A/en not_active IP Right Cessation
- 1989-09-13 AU AU43250/89A patent/AU629248B2/en not_active Expired
- 1989-09-13 EP EP89910146A patent/EP0434721B1/fr not_active Expired - Lifetime
- 1989-09-13 JP JP50949989A patent/JP3292371B2/ja not_active Expired - Lifetime
- 1989-09-13 AU AU42142/89A patent/AU633272B2/en not_active Expired
- 1989-09-13 EP EP96108830A patent/EP0748631B1/fr not_active Expired - Lifetime
- 1989-09-13 WO PCT/GB1989/001076 patent/WO1990002803A2/fr active IP Right Grant
-
1995
- 1995-04-12 IL IL11333995A patent/IL113339A0/xx unknown
-
1996
- 1996-05-29 US US08/654,931 patent/US5744143A/en not_active Expired - Lifetime
-
1997
- 1997-09-25 US US08/938,336 patent/US5958425A/en not_active Expired - Lifetime
-
1998
- 1998-12-30 US US09/223,001 patent/US6100088A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0748631B1 (fr) | 2006-02-08 |
| EP0434747A1 (fr) | 1991-07-03 |
| WO1990002802A3 (fr) | 1990-05-17 |
| US5958425A (en) | 1999-09-28 |
| AU629248B2 (en) | 1992-10-01 |
| EP0748631A3 (fr) | 2000-02-23 |
| IL113339A0 (en) | 1995-07-31 |
| JPH04501658A (ja) | 1992-03-26 |
| IL91627A (en) | 1995-08-31 |
| EP0434747B1 (fr) | 1999-05-19 |
| AU633272B2 (en) | 1993-01-28 |
| WO1990002802A2 (fr) | 1990-03-22 |
| EP0434721B1 (fr) | 2000-03-15 |
| EP0434721A1 (fr) | 1991-07-03 |
| EP0748631A2 (fr) | 1996-12-18 |
| JP3292371B2 (ja) | 2002-06-17 |
| US5744143A (en) | 1998-04-28 |
| AU4214289A (en) | 1990-04-02 |
| WO1990002803A3 (fr) | 1990-05-31 |
| JP3339854B2 (ja) | 2002-10-28 |
| US6100088A (en) | 2000-08-08 |
| AU4325089A (en) | 1990-04-02 |
| JPH04502852A (ja) | 1992-05-28 |
| WO1990002803A2 (fr) | 1990-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL113339A (en) | Mutant viral nucleotide sequences | |
| GB2234972B (en) | Herpes simplex virus type 1 mutant | |
| EP1026246A4 (fr) | Recombinants de virus herpetique infectieux aviaire et vaccins recombinants prepares avec ces derniers | |
| CA2166367A1 (fr) | Vaccin recombinant vivant pour oiseaux, utilisant un virus herpetique aviaire comme vecteur | |
| TNSN97109A1 (fr) | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire | |
| IL116046A0 (en) | DNA construct for modifying the expression characteristics of an endogenous gene and a cell line or microorganism comprising it | |
| CA2366541A1 (fr) | Nouveaux herpesvirus recombinants et mutants | |
| EP0974659A3 (fr) | Séquence nucléotidique virale | |
| EP0481072A4 (en) | Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines | |
| EP0351418A4 (fr) | Systeme de vecteur viral pour l'introduction de produits exprimant un adn etranger chez les volailles gallinacees. | |
| EP1199364A3 (fr) | Utilisation d'enzymes recombinantes pour la préparation de GDP-L-fucose et de glycanes fucosylés | |
| EP0326127A3 (fr) | Mutants d'insertion du virus de la rhinotrachéite infectieuse bovine, vaccins qui les contiennent et procédé pour leur préparation et applications | |
| MXPA01005808A (es) | Cepa de virus de enfermedad bursal infecciosa para administracion en huevo. | |
| DK0606452T3 (da) | Vektorvacciner fra rekombinant katteherpesvirus | |
| AU6998298A (en) | Processes for preparation of Marek's disease virus using continuous mammalian cell lines | |
| CA2188293A1 (fr) | Herpesvirus transformes pour exprimer gd in vitro | |
| MX9702769A (es) | Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek. | |
| EP1161953A3 (fr) | Souche d'IBDV pour l'administration in ovo | |
| Sacks | The role of two immediate-early gene products in the replicative cycle of HSV-1: A genetic approach. | |
| AU6884194A (en) | Specific DNA sequences related to an IBDV protein including vectors, hosts and vaccines | |
| ATE46264T1 (de) | Thymidinkinase-negativ-temperaturbestaendiger rinder herpes-virus-1-mutant als vakzin gegen infektioese rinder-rhinotracheitis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees | ||
| KB | Patent renewed | ||
| KB | Patent renewed |